Pulmonary Vasculopathy Associated with FIGF Gene Mutation

Am J Pathol. 2017 Jan;187(1):25-32. doi: 10.1016/j.ajpath.2016.09.008. Epub 2016 Nov 12.

Abstract

Vascular endothelial growth factor (VEGF)-D is capable of inducing angiogenesis and lymphangiogenesis through signaling via VEGF receptor (VEGFR)-2 and VEGFR-3, respectively. Mutations in the FIGF (c-fos-induced growth factor) gene encoding VEGF-D have not been reported previously. We describe a young male with a hemizygous mutation in the X-chromosome gene FIGF (c.352 G>A) associated with early childhood respiratory deficiency. Histologically, lungs showed ectatic pulmonary arteries and pulmonary veins. The mutation resulted in a substitution of valine to methionine at residue 118 of the VEGF-D protein. The resultant mutant protein had increased dimerization, induced elevated VEGFR-2 signaling, and caused aberrant angiogenesis in vivo. Our observations characterize a new subtype of congenital diffuse lung disease, provide a histological correlate, and support a critical role for VEGF-D in lung vascular development and homeostasis.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Cell Line
  • Chickens
  • Child
  • Child, Preschool
  • Family
  • Genetic Predisposition to Disease*
  • Humans
  • Infant
  • Infant, Newborn
  • Lung / blood supply
  • Lung / metabolism
  • Lung / pathology
  • Lung Diseases / blood
  • Lung Diseases / genetics*
  • Male
  • Mutation / genetics*
  • Neovascularization, Pathologic / genetics
  • Vascular Diseases / blood
  • Vascular Diseases / genetics*
  • Vascular Endothelial Growth Factor D / blood
  • Vascular Endothelial Growth Factor D / genetics*
  • Vascular Endothelial Growth Factor D / metabolism

Substances

  • VEGFD protein, human
  • Vascular Endothelial Growth Factor D